Pharmacological modulation of ghrelin signaling (e.g., AG antagonists or ghrelin receptor blockers) could help mitigate insulin resistance and hyperglycemia, particularly in individuals with low Akkermansia levels. The gene discussed is GHSR; the disease is Insulin resistance.